More information: Jacqueline Fátima Martins de Almeida et al, Molecular aspects of Angelman Syndrome: Defining the new path forward, Biomolecules and Biomedicine (2025). DOI: 10.17305/bb.2025.11724 ...

One of the best-understood epigenetic mechanisms—genomic imprinting—explains much about both sleep and the brain.

It is named after Dr. Harry Angelman, and English physician who first described the condition in 1965. The disorder is rare, affecting around one in 12,000 to 20,000 people, the Cleveland Clinic ...

NOVATO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that it has ...

The actor’s son James has Angelman syndrome, a rare neurogenetic disorder. The Colin Farrell Foundation aims to raise awareness about intellectual disability.

Actor Colin Farrell publicizes that his son, James, has Angelman Syndrome. Here's what Angelman Syndrome is, and if a cure is near.

Angelman syndrome is a rare neurogenetic disorder affecting approximately 1 in 15,000 live births or 500,000 people globally. It results from the loss of function of the UBE3A gene located on the ...

Actor Colin Farrell is launching a new foundation to raise awareness of a rare genetic condition called Angelman syndrome, so that his son and others with the disorder will have more support and ...

Actor Colin Farrell has opened up about the difficult decision to move his son James, who has Angelman syndrome, into a long-term care facility.. The Oscar-nominated star of The Banshees of ...

Ionis Pharmaceuticals is looking ahead to a Phase 3 study for an antisense medicine it is developing to treat Angelman syndrome, a rare neurodevelopmental disorder with no FDA-approved therapies.

Angelman syndrome affects an estimated 15,000 to 500,000 people worldwide. ... imprinting defects, point mutations in UBE3A, and cases with unknown origins.